Literature DB >> 19711127

Dysphagia in head and neck cancer patients treated with chemoradiotherapy.

Nele Platteaux1, Piet Dirix, Eddy Dejaeger, Sandra Nuyts.   

Abstract

Dysphagia is a very common complaint of head and neck cancer patients and can exist before, during, and after chemoradiotherapy. It leads to nutritional deficiency, weight loss, and prolonged unnatural feeding and also has a major potential risk for aspiration. This has a significant negative impact on the patient's entire quality of life. Because treatment of dysphagia in this setting is rarely effective, prevention is paramount. Several strategies have been developed to reduce dysphagia. These include swallowing exercises, treatment modification techniques such as intensity-modulated radiotherapy, selective delineation of elective nodes, reducing xerostomia by parotid-sparing radiotherapy, and adding of radioprotectors. However, more research is needed to further decrease the incidence of dysphagia and improve quality of life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19711127     DOI: 10.1007/s00455-009-9247-7

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  89 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Quality of life and head and neck cancer: a 5 year prospective study.

Authors:  Helmut Abendstein; Mats Nordgren; Morten Boysen; Magnus Jannert; Ewa Silander; Marianne Ahlner-Elmqvist; Eva Hammerlid; Kristin Bjordal
Journal:  Laryngoscope       Date:  2005-12       Impact factor: 3.325

3.  Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation.

Authors:  Jeri A Logemann; Alfred W Rademaker; Barbara Roa Pauloski; Cathy L Lazarus; Bharat B Mittal; Bruce Brockstein; Ellen MacCracken; Daniel J Haraf; Everett E Vokes; Lisa A Newman; Dachao Liu
Journal:  Head Neck       Date:  2006-01       Impact factor: 3.147

4.  Evaluation of swallowing safety with fiberoptic endoscope: comparison with videofluoroscopic technique.

Authors:  C H Wu; T Y Hsiao; J C Chen; Y C Chang; S Y Lee
Journal:  Laryngoscope       Date:  1997-03       Impact factor: 3.325

5.  Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.

Authors:  Dosia Antonadou; Marizenia Pepelassi; Maria Synodinou; Maria Puglisi; Nicolas Throuvalas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-01       Impact factor: 7.038

6.  Pretreatment swallowing function in patients with head and neck cancer.

Authors:  B R Pauloski; A W Rademaker; J A Logemann; D Stein; Q Beery; L Newman; C Hanchett; S Tusant; E MacCracken
Journal:  Head Neck       Date:  2000-08       Impact factor: 3.147

Review 7.  Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck.

Authors:  M A List; J Stracks
Journal:  Curr Opin Oncol       Date:  2000-05       Impact factor: 3.645

8.  Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation.

Authors:  Jeri A Logemann; Barbara Roa Pauloski; Alfred W Rademaker; Cathy L Lazarus; Bharat Mittal; Joy Gaziano; Linda Stachowiak; Ellen MacCracken; Lisa A Newman
Journal:  Head Neck       Date:  2003-06       Impact factor: 3.147

9.  Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.

Authors:  Sandra Nuyts; Piet Dirix; Paul M J Clement; Vincent Vander Poorten; Pierre Delaere; Joseph Schoenaers; Robert Hermans; Walter Van den Bogaert
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-15       Impact factor: 7.038

10.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.

Authors:  D M Brizel; M E Albers; S R Fisher; R L Scher; W J Richtsmeier; V Hars; S L George; A T Huang; L R Prosnitz
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

View more
  40 in total

1.  Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up.

Authors:  Sandra Ottosson; Ulrika Lindblom; Peter Wahlberg; Per Nilsson; Elisabeth Kjellén; Björn Zackrisson; Eva Levring Jäghagen; Göran Laurell
Journal:  Support Care Cancer       Date:  2014-04-01       Impact factor: 3.603

2.  Effects of chin-up posture on the sequence of swallowing events.

Authors:  Irene Calvo; Kirstyn L Sunday; Phoebe Macrae; Ianessa A Humbert
Journal:  Head Neck       Date:  2017-02-09       Impact factor: 3.147

Review 3.  Systematic review of dose--volume correlates for structures related to late swallowing disturbances after radiotherapy for head and neck cancer.

Authors:  Fréderic Duprez; Indira Madani; Bruno De Potter; Tom Boterberg; Wilfried De Neve
Journal:  Dysphagia       Date:  2013-02-22       Impact factor: 3.438

4.  Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin.

Authors:  Wuyang Yang; Todd R McNutt; Sara A Dudley; Rachit Kumar; Heather M Starmer; Christine G Gourin; Joseph A Moore; Kimberly Evans; Mysha Allen; Nishant Agrawal; Jeremy D Richmon; Christine H Chung; Harry Quon
Journal:  Dysphagia       Date:  2016-01-11       Impact factor: 3.438

Review 5.  Therapeutic Implications of the Genetic Landscape of Head and Neck Cancer.

Authors:  Janice Cho; Daniel E Johnson; Jennifer R Grandis
Journal:  Semin Radiat Oncol       Date:  2018-01       Impact factor: 5.934

6.  Factors associated with gastrostomy tube dependence after concurrent chemoradiotherapy for hypopharyngeal cancer.

Authors:  Shigeyuki Murono; Akira Tsuji; Kazuhira Endo; Satoru Kondo; Naohiro Wakisaka; Tomokazu Yoshizaki
Journal:  Support Care Cancer       Date:  2014-08-17       Impact factor: 3.603

7.  Effects of laryngeal restriction on pharyngeal peristalsis and biomechanics: Clinical implications.

Authors:  Reza Shaker; Patrick Sanvanson; Gokulakrishnan Balasubramanian; Mark Kern; Ashley Wuerl; Allison Hyngstrom
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-14       Impact factor: 4.052

8.  Does the total dysphagia risk score correlate with swallowing function examined by videofluoroscopy?

Authors:  Daan Nevens; Ann Goeleven; Fréderic Duprez; R Braeken; E Decabooter; M De Smet; L Lutters; Eddy Dejaeger; Wilfried De Neve; Sandra Nuyts
Journal:  Br J Radiol       Date:  2018-01-02       Impact factor: 3.039

9.  Clinical observation and quality of life in terms of nasal sinusitis after radiotherapy for nasopharyngeal carcinoma: long-term results from different nasal irrigation techniques.

Authors:  H-H Luo; Z-C Fu; H-H Cheng; S-G Liao; D-S Li; L-P Cheng
Journal:  Br J Radiol       Date:  2014-05-12       Impact factor: 3.039

10.  Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.

Authors:  L Deantonio; L Masini; M Brambilla; F Pia; M Krengli
Journal:  Strahlenther Onkol       Date:  2013-01-16       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.